New software aims to perfect heart ablation by reading electrical signals

NCT ID NCT07379697

Not yet recruiting Knowledge-focused Sponsor: CathVision ApS Source: ClinicalTrials.gov ↗

First seen Jun 27, 2026 · Last updated Jun 27, 2026

Summary

This study will test a new software system that measures tiny electrical signals in the heart after a procedure called pulsed field ablation, used to treat atrial fibrillation (an irregular heartbeat). Researchers will enroll 30 adults with AF who are already scheduled for ablation. The goal is to find a clear signal level that tells doctors the treatment is complete, which could lead to more consistent and effective procedures in the future.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: ECGenius System with PFAnalyzer software
What this could lead to: If successful, this could help doctors better determine when a heart ablation is complete, potentially improving outcomes for atrial fibrillation patients.
What could go wrong: This is a small, early observational study with only 30 participants, so results may not apply to all patients. It does not test a new treatment, only a measurement method.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ATRIAL FIBRILLATION (AF) are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

atrial fibrillation

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ATRIAL FIBRILLATION (AF)

More trials for these conditions

Other studies related to the condition(s) this trial covers.